Cargando…
An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice
Malstructured glycogen accumulates over time in Lafora disease (LD) and precipitates into Lafora bodies (LBs), leading to neurodegeneration and intractable fatal epilepsy. Constitutive reduction of glycogen synthase-1 (GYS1) activity prevents murine LD, but the effect of GYS1 reduction later in dise...
Autores principales: | Nitschke, Silvia, Chown, Erin E., Zhao, Xiaochu, Gabrielian, Shoghig, Petković, Sara, Guisso, Dikran R., Perri, Ami M., Wang, Peixiang, Ahonen, Saija, Nitschke, Felix, Minassian, Berge A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857511/ https://www.ncbi.nlm.nih.gov/pubmed/33277363 http://dx.doi.org/10.1074/jbc.RA120.015773 |
Ejemplares similares
-
Ketogenic diet reduces Lafora bodies in murine Lafora disease
por: Israelian, Lori, et al.
Publicado: (2020) -
Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy
por: Mitra, Sharmistha, et al.
Publicado: (2023) -
Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease
por: Nitschke, Felix, et al.
Publicado: (2017) -
Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan
por: Sullivan, Mitchell A., et al.
Publicado: (2017) -
Lafora disease in miniature Wirehaired Dachshunds
por: Swain, Lindsay, et al.
Publicado: (2017)